• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

利用 Sendai 病毒载体进行直接重编程修复了慢性阶段的梗死心脏。

Direct reprogramming with Sendai virus vectors repaired infarct hearts at the chronic stage.

机构信息

Department of Cardiology, Faculty of Medicine, University of Tsukuba, 1-1-1 Tennoudai, Tsukuba City, Ibaraki, 305-8575, Japan.

Department of Cardiology, Faculty of Medicine, University of Tsukuba, 1-1-1 Tennoudai, Tsukuba City, Ibaraki, 305-8575, Japan; Division of Regenerative Medicine, Transborder Medical Research Center, University of Tsukuba, 1-1-1 Tennoudai, Tsukuba City, Ibaraki, 305-8575, Japan.

出版信息

Biochem Biophys Res Commun. 2021 Jun 30;560:87-92. doi: 10.1016/j.bbrc.2021.04.121. Epub 2021 May 10.

DOI:10.1016/j.bbrc.2021.04.121
PMID:33984769
Abstract

Adult hearts have limited regenerative capacity. Hence, after acute myocardial infarction (MI), dead myocardial tissues are digested by immune cells and replaced by fibrosis, leading to ventricular remodeling and heart failure at the chronic stage. Direct reprogramming of the cardiac fibroblasts (CFs) into induced cardiomyocytes (iCMs) with cardiac transcription factors, including Gata4, Mef2c, and Tbx5 (GMT), may have significant potential for cardiac repair. Sendai virus (SeV) vectors expressing GMT have been reported to reprogram the mouse cardiac fibroblasts into iCMs without any risk of insertional mutagenesis. In vivo reprogramming improved the cardiac function after acute MI in immunodeficient mice. However, it is unknown whether the newly generated iCMs could exist in infarct hearts for a prolonged period and SeV-GMT can improve cardiac function after MI at the chronic stage in immunocompetent mice. Here, we show that SeV vectors efficiently infect CFs in vivo and reprogram them into iCMs, which existed for at least four weeks after MI, in fibroblast-linage tracing mice. Moreover, SeV-GMT improved cardiac function and reduced fibrosis and collagen I expression at 12 weeks after MI in immunocompetent mice. Thus, direct cardiac reprogramming with SeV vectors could be a promising therapy for MI.

摘要

成人心脏的再生能力有限。因此,急性心肌梗死 (MI) 后,死亡的心肌组织被免疫细胞消化,并被纤维化取代,导致慢性阶段心室重构和心力衰竭。心脏转录因子(包括 Gata4、Mef2c 和 Tbx5 (GMT))直接将心脏成纤维细胞 (CFs) 重编程为诱导性心肌细胞 (iCMs),可能具有显著的心脏修复潜力。表达 GMT 的仙台病毒 (SeV) 载体已被报道可将小鼠心脏成纤维细胞重编程为 iCMs,而不存在插入突变的风险。在免疫缺陷小鼠中,体内重编程可改善急性 MI 后的心脏功能。然而,尚不清楚新生成的 iCMs 是否能在梗死心脏中存在较长时间,以及 SeV-GMT 是否能改善免疫功能正常小鼠慢性阶段 MI 后的心脏功能。在这里,我们发现在纤维化谱系追踪小鼠中,SeV 载体可有效感染体内的 CFs 并将其重编程为 iCMs,这些 iCMs 在 MI 后至少存在四周。此外,SeV-GMT 可改善 MI 后 12 周免疫功能正常小鼠的心脏功能,并减少纤维化和胶原 I 的表达。因此,用 SeV 载体进行直接心脏重编程可能是一种有前途的 MI 治疗方法。

相似文献

1
Direct reprogramming with Sendai virus vectors repaired infarct hearts at the chronic stage.利用 Sendai 病毒载体进行直接重编程修复了慢性阶段的梗死心脏。
Biochem Biophys Res Commun. 2021 Jun 30;560:87-92. doi: 10.1016/j.bbrc.2021.04.121. Epub 2021 May 10.
2
Direct In Vivo Reprogramming with Sendai Virus Vectors Improves Cardiac Function after Myocardial Infarction.仙台病毒载体的直接体内重编程可改善心肌梗死后的心脏功能。
Cell Stem Cell. 2018 Jan 4;22(1):91-103.e5. doi: 10.1016/j.stem.2017.11.010. Epub 2017 Dec 21.
3
Direct Reprogramming Improves Cardiac Function and Reverses Fibrosis in Chronic Myocardial Infarction.直接重编程改善慢性心肌梗死的心脏功能并逆转纤维化。
Circulation. 2023 Jan 17;147(3):223-238. doi: 10.1161/CIRCULATIONAHA.121.058655. Epub 2022 Dec 12.
4
Development of adeno-associated viral vectors targeting cardiac fibroblasts for efficient in vivo cardiac reprogramming.针对心肌成纤维细胞的腺相关病毒载体的开发用于有效的体内心脏重编程。
Stem Cell Reports. 2024 Oct 8;19(10):1389-1398. doi: 10.1016/j.stemcr.2024.08.002. Epub 2024 Sep 5.
5
Induction of cardiomyocyte-like cells in infarct hearts by gene transfer of Gata4, Mef2c, and Tbx5.通过基因转染 Gata4、Mef2c 和 Tbx5 在梗死心脏中诱导心肌细胞样细胞。
Circ Res. 2012 Oct 12;111(9):1147-56. doi: 10.1161/CIRCRESAHA.112.271148. Epub 2012 Aug 28.
6
Direct Cardiac Reprogramming: A Novel Approach for Heart Regeneration.直接心脏重编程:心脏再生的新方法。
Int J Mol Sci. 2018 Sep 5;19(9):2629. doi: 10.3390/ijms19092629.
7
The Future of Direct Cardiac Reprogramming: Any Cocktail Variety?直接心脏重编程的未来:鸡尾酒疗法?
Int J Mol Sci. 2020 Oct 26;21(21):7950. doi: 10.3390/ijms21217950.
8
In vivo reprogramming of murine cardiac fibroblasts into induced cardiomyocytes.在体重编程鼠心肌成纤维细胞为诱导性心肌细胞。
Nature. 2012 May 31;485(7400):593-8. doi: 10.1038/nature11044.
9
Cardiac regeneration with pluripotent stem cell-derived cardiomyocytes and direct cardiac reprogramming.利用多能干细胞衍生的心肌细胞进行心脏再生及直接心脏重编程。
Regen Ther. 2019 Jun 27;11:95-100. doi: 10.1016/j.reth.2019.06.004. eCollection 2019 Dec.
10
Cardiac reprogramming reduces inflammatory macrophages and improves cardiac function in chronic myocardial infarction.心脏重编程可减少慢性心肌梗死中的炎症性巨噬细胞并改善心脏功能。
Biochem Biophys Res Commun. 2024 Jan 1;690:149272. doi: 10.1016/j.bbrc.2023.149272. Epub 2023 Nov 18.

引用本文的文献

1
Cell and tissue reprogramming: Unlocking a new era in medical drug discovery.细胞与组织重编程:开启药物研发的新时代。
Pharmacol Rev. 2025 Jun 26;77(5):100077. doi: 10.1016/j.pharmr.2025.100077.
2
Decoding the epigenetic and transcriptional basis of direct cardiac reprogramming.解析直接心脏重编程的表观遗传和转录基础。
Stem Cells. 2025 Mar 10;43(3). doi: 10.1093/stmcls/sxaf002.
3
Control of cell fate upon transcription factor-driven cardiac reprogramming.转录因子诱导的心脏重编程过程中对细胞命运的控制。
Curr Opin Genet Dev. 2024 Dec;89:102226. doi: 10.1016/j.gde.2024.102226.
4
DIRECTEUR: transcriptome-based prediction of small molecules that replace transcription factors for direct cell conversion.基于转录组学的小分子预测,这些小分子可替代转录因子实现细胞的直接转化。
Bioinformatics. 2024 Feb 1;40(2). doi: 10.1093/bioinformatics/btae048.
5
Vitamin C facilitates direct cardiac reprogramming by inhibiting reactive oxygen species.维生素 C 通过抑制活性氧来促进心脏的直接重编程。
Stem Cell Res Ther. 2024 Jan 17;15(1):19. doi: 10.1186/s13287-023-03615-x.
6
Can we stop one heart from breaking: triumphs and challenges in cardiac reprogramming.能否阻止心脏破裂:心脏重编程的成功与挑战。
Curr Opin Genet Dev. 2023 Dec;83:102116. doi: 10.1016/j.gde.2023.102116. Epub 2023 Oct 3.
7
Direct Reprogramming of Resident Non-Myocyte Cells and Its Potential for In Vivo Cardiac Regeneration.常驻非心肌细胞的直接重编程及其在体内心脏再生中的潜力。
Cells. 2023 Apr 15;12(8):1166. doi: 10.3390/cells12081166.
8
Post-myocardial infarction fibrosis: Pathophysiology, examination, and intervention.心肌梗死后纤维化:病理生理学、检查与干预
Front Pharmacol. 2023 Mar 28;14:1070973. doi: 10.3389/fphar.2023.1070973. eCollection 2023.
9
Direct cardiac reprogramming: A new technology for cardiac repair.直接心脏重编程:心脏修复的新技术。
J Mol Cell Cardiol. 2023 May;178:51-58. doi: 10.1016/j.yjmcc.2023.03.008. Epub 2023 Mar 23.
10
Cellular reprogramming of fibroblasts in heart regeneration.成纤维细胞的细胞重编程在心脏再生中。
J Mol Cell Cardiol. 2023 Jul;180:84-93. doi: 10.1016/j.yjmcc.2023.03.009. Epub 2023 Mar 23.